Bessmel'tsev S S, Fedorova Z D, Abdulkadyrov K M
Gematol Transfuziol. 1990 Jul;35(7):13-5.
Rheologic properties of red blood cells and hemostasis were studied in patients with acquired autoimmune hemolytic anemia who received antilymphocytic globulin (ALG). Hypocoagulation changes attended by elevation of red blood cell aggregation activity were detected in the patients already at their admission to the hospital. After administration of ALG, growth of these shifts, characteristic of disseminated intravascular blood coagulation (DIC) syndrome, was noted. It was shown that erythrocytic thromboplastin and antiheparin factor action on blood coagulation, mainly at the expense of the young cell fraction, was responsible for disorders in hemostasis. Nevertheless, despite the presence of DIC syndrome, in the group of patients, who received ALG, no clinical signs of this state were recorded, that could be explained by the protective effect of red blood cell intensified capacity for aggregation leading to the improvement of blood coagulation parameters.
对接受抗淋巴细胞球蛋白(ALG)治疗的获得性自身免疫性溶血性贫血患者的红细胞流变学特性和止血情况进行了研究。在患者入院时就检测到了伴有红细胞聚集活性升高的低凝变化。给予ALG后,发现这些变化加剧,具有弥散性血管内凝血(DIC)综合征的特征。结果表明,红细胞凝血活酶和抗肝素因子对血液凝固的作用,主要是以年轻细胞部分为代价,是导致止血障碍的原因。然而,尽管存在DIC综合征,但在接受ALG治疗的患者组中,未记录到该状态的临床体征,这可以通过红细胞增强的聚集能力的保护作用来解释,这种作用导致了凝血参数的改善。